Nuevolution Sitemap Nuevolution
February 21, 2014
Nuevolution announces license agreement with Merck
January 22, 2014
Nuevolution enter drug discovery collaboration with The Institute of Cancer
Research and Cancer Research Technology
January 10, 2014
November 4, 2013
Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs


Chemetics® - A Quantum Leap for Small Molecule Lead Discovery

Nuevolution is a company dedicated to revolutionize fragment and HTS based lead discovery by applying its proprietary Chemetics® technologies enabling unprecedented synthesis and screening power for rapid and cost-efficient identification of drug leads.

Chemetics® represents the ultimate “convergent” drug discovery technology – a unique, patent protected fusion of proven wet chemistry and molecular biology methods producing an unrivaled capacity for synthesis and screening of millions to billions of drug-like molecules in a single test tube.

Nuevolution has demonstrated the power of Chemetics® by identification of highly potent and drug like novel ligands with the potential to address major unmet medical needs across a range of therapeutic areas and target classes. Nuevolutions internal programs focuses on therapeutically important targets within inflammation and oncology.






Discover ChemeticsDiscover Nuevolution
(c) 2014 Nuevolution A/S
Home Sitemap Nuevolution